Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Development of non-alcoholic steatohepatitis is associated with gut microbiota but not oxysterol synthesis

View ORCID ProfileJacqueline Wyss, Tina Raselli, Annika Wyss, View ORCID ProfileAnja Telzerov, View ORCID ProfileGerhard Rogler, View ORCID ProfileNiklas Krupka, View ORCID ProfileBahtiyar Yilmaz, View ORCID ProfileThomas SB Schmidt, View ORCID ProfileBenjamin Misselwitz
doi: https://doi.org/10.1101/2022.12.02.518833
Jacqueline Wyss
1Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jacqueline Wyss
Tina Raselli
2Department of Gastroenterology and Hepatology, University Hospital Zurich and University of Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annika Wyss
2Department of Gastroenterology and Hepatology, University Hospital Zurich and University of Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anja Telzerov
3Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anja Telzerov
Gerhard Rogler
2Department of Gastroenterology and Hepatology, University Hospital Zurich and University of Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gerhard Rogler
Niklas Krupka
1Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Niklas Krupka
Bahtiyar Yilmaz
1Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
4Maurice Müller Laboratories, Department for Biomedical Research, University of Bern, 3008, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bahtiyar Yilmaz
Thomas SB Schmidt
3Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas SB Schmidt
  • For correspondence: sebastian.schmidt@embl.de
Benjamin Misselwitz
1Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
2Department of Gastroenterology and Hepatology, University Hospital Zurich and University of Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Benjamin Misselwitz
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

Liver steatosis is the most frequent liver disorder and its advanced stage, non-alcoholic steatohepatitis (NASH), will soon become the main reason for liver fibrosis and cirrhosis. The “multiple hits hypothesis” suggests that progression from simple steatosis to NASH is triggered by multiple factors including the gut microbiota composition. The Epstein Barr virus induced gene 2 (EBI2) is a receptor for the oxysterol 7a, 25-dihydroxycholesterol synthesized by the enzymes CH25H and CYP7B1. EBI2 and its ligand control activation of immune cells in secondary lymphoid organs and the gut. Here we show a concurrent study of the microbial dysregulation and perturbation of the EBI2 axis in a mice model of NASH.

We used mice with wildtype, or littermates with CH25H-/-, EBI2-/-, or CYP7B1-/- genotypes fed with a high-fat diet (HFD) containing high amounts of fat, cholesterol, and fructose for 20 weeks to induce liver steatosis and NASH. Fecal and small intestinal microbiota samples were collected, and microbiota signatures were compared according to genotype and NASH disease state.

We found pronounced differences in microbiota composition of mice with HFD developing NASH compared to mice did not developing NASH. In mice with NASH, we identified significantly increased 33 taxa mainly belonging to the Clostridiales order and/ or the family, and significantly decreased 17 taxa. Using an Elastic Net algorithm, we suggest a microbiota signature that predicts NASH in animals with a HFD from the microbiota composition with moderate accuracy (area under the receiver operator characteristics curve=0.64). In contrast, no microbiota differences regarding the studied genotypes (wildtype vs knock-out CH25H-/-, EBI2-/-, or CYP7B1-/-) were observed.

In conclusion, our data confirm previous studies identifying the intestinal microbiota composition as a relevant marker for NASH pathogenesis. Further, no link of the EBI2 – oxysterol axis to the intestinal microbiota was detectable in the current study.

Competing Interest Statement

The authors have declared no competing interest.

  • Abbreviations

    NAFLD
    non-alcoholic fatty liver disease
    NASH
    non-alcoholic steatohepatitis
    FFA
    free fatty acids
    OTU
    operational taxonomic unit
    AUROC
    area under the receiver operating characteristic curve
    EBI2
    Epstein Barr virus-induced gene 2 - also known as GPR183
    CH25H
    cholesterol 25-hydroxylase
    CYP7B1
    cytochrome P450 7B1
    7a, 25-diHC
    7α,25-dihydroxycholesterol
    25-OHC
    25-hydroxycholesterol
    27-OHC
    27-hydroxycholesterol
    24(S)-OHC
    24-S-hydroxycholesterol
    7-OHC
    7-hydroxycholesterol
    HFD
    high fat diet
    STD
    standard diet
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
    Back to top
    PreviousNext
    Posted December 02, 2022.
    Download PDF

    Supplementary Material

    Email

    Thank you for your interest in spreading the word about bioRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Development of non-alcoholic steatohepatitis is associated with gut microbiota but not oxysterol synthesis
    (Your Name) has forwarded a page to you from bioRxiv
    (Your Name) thought you would like to see this page from the bioRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Development of non-alcoholic steatohepatitis is associated with gut microbiota but not oxysterol synthesis
    Jacqueline Wyss, Tina Raselli, Annika Wyss, Anja Telzerov, Gerhard Rogler, Niklas Krupka, Bahtiyar Yilmaz, Thomas SB Schmidt, Benjamin Misselwitz
    bioRxiv 2022.12.02.518833; doi: https://doi.org/10.1101/2022.12.02.518833
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Development of non-alcoholic steatohepatitis is associated with gut microbiota but not oxysterol synthesis
    Jacqueline Wyss, Tina Raselli, Annika Wyss, Anja Telzerov, Gerhard Rogler, Niklas Krupka, Bahtiyar Yilmaz, Thomas SB Schmidt, Benjamin Misselwitz
    bioRxiv 2022.12.02.518833; doi: https://doi.org/10.1101/2022.12.02.518833

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Microbiology
    Subject Areas
    All Articles
    • Animal Behavior and Cognition (4113)
    • Biochemistry (8815)
    • Bioengineering (6519)
    • Bioinformatics (23463)
    • Biophysics (11790)
    • Cancer Biology (9209)
    • Cell Biology (13323)
    • Clinical Trials (138)
    • Developmental Biology (7438)
    • Ecology (11410)
    • Epidemiology (2066)
    • Evolutionary Biology (15151)
    • Genetics (10436)
    • Genomics (14044)
    • Immunology (9171)
    • Microbiology (22154)
    • Molecular Biology (8812)
    • Neuroscience (47570)
    • Paleontology (350)
    • Pathology (1428)
    • Pharmacology and Toxicology (2491)
    • Physiology (3730)
    • Plant Biology (8080)
    • Scientific Communication and Education (1437)
    • Synthetic Biology (2221)
    • Systems Biology (6037)
    • Zoology (1253)